Evaluating interference caused by lipemia

Clinical Chemistry

Volumn 50, Issue 11, 2004, Pages 1968-1969

  Kroll, Martin H ^a  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BILIRUBIN; CHYLOMICRON; ESTROGEN; HEMOGLOBIN; INTRALIPID; STEROID; VERY LOW DENSITY LIPOPROTEIN;

ANALYTIC METHOD; CHRONIC KIDNEY FAILURE; CLINICAL LABORATORY; DIABETES MELLITUS; EDITORIAL; EMULSION; HEMOLYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPOTHYROIDISM; JAUNDICE; LIGHT SCATTERING; MULTIPLE MYELOMA; PANCREATITIS; PRIMARY BILIARY CIRRHOSIS; SPECTROPHOTOMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL PARENTERAL NUTRITION;

BLOOD CHEMICAL ANALYSIS; FALSE NEGATIVE REACTIONS; FAT EMULSIONS, INTRAVENOUS; HUMANS; IMMUNOASSAY; LIGHT; LIPIDS; NEPHELOMETRY AND TURBIDIMETRY; SCATTERING, RADIATION; TRIGLYCERIDES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 7044241205     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.038075     Document Type: Editorial

References (14)

1. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40:1996-2005.
2. Glick MR, Ryder KW, Glick SJ. Interferographs: user's guide to interferences in clinical chemistry instruments, 2nd ed. Indianapolis: Science Enterprises, Inc., 1991:9-17.
3. Bornhorst JA, Roberts RF, Roberts WL. Assay-specific differences in lipemic interference in native and Intralipid-supplemented samples. Clin Chem 2004;50:2197-201.
4. Tanford C. Physical chemistry of macromolecules. New York: Wiley and Sons, 1961:275-316.
5. Nassau K. The physics and chemistry of color. New York: Wiley and Sons, 1983:232-42.
6. Cantor CR, Schimmel PR. Biophysical chemistry. San Francisco: W.H. Freeman & Co., 1980:838-45.
7. Weiner I, Rust M, Donnelly TD. Particle size determination: an undergraduate lab in Mie scattering. Am J Phys 2001;69:129-36.
8. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003;52:453-62.
9. Park Y, Grellner, Harris WS, Miles JM. A new method for the study of chylomicron kinetics in vivo. Am J Physiol Endocrinol Metab 2000;279: E1258-63.
10. Sonntag O, Glick MR. Serum-Index und interferogramm-Ein neuer Weg zur Prufung und Darstellung von Interferenzen durch Serumchromogene. Lab Med 1989;13:77-82.
11. Baxter Healthcare. IntraLipid [Package insert]. Deerfield, IL: Fresenius Kabi, Baxter Healthcare Corporation, 2000.
12. Wabel C. Influence of lecithin on structure and stability of parenteral fat emulsions. Doctoral thesis. Nurnberg: Den Naturwissenschaftlichen Fakultaten der Friedrich-Alexander-Universitat Erlangen, July 30, 1998.
13. Creer MH, Ladenson J. Analytical errors due to lipemia. Lab Med 1983;14:351-5.
14. Miller M. Giving triglycerides their due. Hosp Pract 1999;34:67-73.